Activation of Blood Coagulation, Fibrinolytic and Kallikrein Systems during Storage of Plasma
- 1 November 1984
- journal article
- research article
- Published by Wiley in Vox Sanguinis
- Vol. 47 (5), 335-342
- https://doi.org/10.1111/j.1423-0410.1984.tb04136.x
Abstract
This study deals with the question of how blood coagulation, kallikrein and fibrinolytic systems are affected by storage of plasma at +6.degree. C. Blood was collected into citrate phosphate dextrose adenine (CPD) or acid citrate dextrose (ACD) and the plasma samples were stored at +6.degree. C for 35 days. Samples were taken at weekly intervals for assays of various parameters of the different systems. No significant changes were observed in the levels of the main thrombin inhibitor, antithrombin III. At the end of the storage period, fibrinopeptide A levels increased markedly, particularly in the ACD plasma, indicating thrombin activation. There was no change in the plasminogen level, but a decrease in the levels of antiplasmin and urokinase inhibitors and an increase in the level of the fibrinogen degradation fragment B.beta. 15-42 were observed, indicating activation of the fibrinolytic system. The level of antikallikrein activity decreased sharply in ACD plasma; CPD plasma was less affected. This decrease was parallel to the increase in spontaneous proteolytic activity and correlated with the increase in fibrinopeptide A. Prolonged storage of plasma at +6.degree. C resulted in the activation of coagulation, fibrinolytic and kallikrein systems and decrease in inhibitors. The activation was much more pronounced in ACD than in CPD plasma.This publication has 15 references indexed in Scilit:
- Shelf‐life of bank blood and stored plasma with special reference to coagulation factorsTransfusion, 1983
- Improvement of Plasma Quality as Raw Material for Factor VIII:C ConcentratesVox Sanguinis, 1983
- Simple chromogenic peptide substrate assays for determining prekallikrein, kallikrein inhibition and kallikrein “like” activity in human plasmaThrombosis Research, 1982
- Measurement in human blood of fibrinogen/fibrin fragments containing the bβ 15–42 sequenceThrombosis Research, 1982
- Contribution of Plasma Protease Inhibitors to the Inactivation of Kallikrein in PlasmaJournal of Clinical Investigation, 1982
- Rapid radioimmunoassay of human fibrinopeptide A — Removal of cross-reacting fibrinogen with bentoniteThrombosis Research, 1980
- Evidence for the participation of both activated factor XII and activated factor IX in cold-promoted activation of factor VIIThrombosis Research, 1978
- Antithrombin (heparin cofactor) assay with “new” chromogenic substrates (S-2238 and Chromozym TH)Thrombosis Research, 1977
- Determination of a new rapid plasmin inhibitor in human blood by means of a plasmin specific tripeptide substrateScandinavian Journal of Clinical and Laboratory Investigation, 1977
- Measurement of Fibrinopeptide A in Human BloodJournal of Clinical Investigation, 1974